Last reviewed · How we verify

NCT06805916

Promoting Communication in Minimally Verbal Autistic Children with Social Robot

ENROLLING BY INVITATION NA Last updated 11 February 2025
What this trial tests

NA trial testing NAO-Assisted Therapy in Autism Spectrum Disorder in 100 participants. Enrolling by invitation.

Timeline
2 January 2023
Primary endpoint
30 September 2025
30 September 2025

Quick facts

Lead sponsorIRCCS Centro Neurolesi Bonino Pulejo
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment100
Start date2 January 2023
Primary completion30 September 2025
Estimated completion30 September 2025
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

IRCCS Centro Neurolesi Bonino Pulejo — full company profile →

Who can join

Adults 4 to 12, any sex, with Autism Spectrum Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Minimally verbal (MV) children with Autism Spectrum Disorder (ASD) face significant challenges in communication and social interaction, which are fundamental to learning and development. Current therapeutic approaches, such as speech therapy and augmentative communication systems, often have variable efficacy due to engagement and responsiveness challenges. This pilot study investigates using of the humanoid robot NAO as part of a rehabilitative program designed for MV children with ASD. NAO, with its predictable and engaging interaction style, is hypothesized to enhance communicative initiative, expressive communication, and social interaction in this population. The study employs a randomized controlled trial design, assigning participants to either an NAO-assisted intervention group or a control group receiving standard therapy. Outcomes will be assessed using standardized measures of communication, social interaction, and observational data. This research aims to explore the potential of social robots as an innovative tool to addressing the unique needs of MV children with ASD, contributing to the development of effective, accessible therapeutic options that improve their quality of life and that of their families.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Enhancing Communication in Minimally Verbal Autistic Children: A Study on NAO-Assisted Therapy.
    Di Cara M, La Fauci M, Tresoldi M, Caputo MR, et al · · 2025 · cited 1× · PMID 40507497 · DOI 10.3390/jcm14113735

Verify or expand the search:

Other recruiting trials for Autism Spectrum Disorder

Currently open trials in the same condition.

Other IRCCS Centro Neurolesi Bonino Pulejo trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06805916.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing